至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

MiR-193a-3p is an Important Tumour Suppressor in Lung Cancer and Directly Targets KRAS.

Cell Physiol Biochem.. 2017-11; 
Fan Q, Hu X, Zhang H, Wang S, Zhang H, You C, Zhang CY, Liang H, Chen X, Ba Y.
Products/Services Used Details Operation
Catalog Products … China). The A549-Luc cells were produced by GenScript (Nanjing, China). All cells were cultured in Dulbecco's modified Eagle's medium (DMEM; GIBCO, Carlsbad, CA, USA) supplemented with 10% foetal bovine serum (GIBCO) … Get A Quote

摘要

BACKGROUND/AIMS: MicroRNAs (miRNAs) have emerged as major regulators of tumour development and progression in non-small cell lung cancer (NSCLC). However, the role of miR-193a-3p in NSCLC is still unclear. METHODS: Quantitative RT-PCR was used to detect miR-193a-3p expression levels in NSCLC tumour tissues. CCK8, EdU and cell migration assays were performed to analyse the biological functions of miR-193a-3p in NSCLC cells. Luciferase reporter assays were used to validate the bioinformatics-predicted target genes of miR-193a-3p. Western blotting and RNA/DNA interference carried out to evaluate the association between miR-193a-3p and KRAS. RESULTS: miR-193a-3p expression was decreased in the NSCLC tumour tissues.... More

关键词

KRAS; MicroRNA; NSCLC; miR-193a-3p